Immediate Impact
46 standout
Citing Papers
HER2-targeted therapies in cancer: a systematic review
2024 Standout
The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors
2024 Standout
Works of Enrichetta Valle being referenced
Ado-Trastuzumab Emtansine (T-DM1) in HER2+ Advanced Breast Cancer Patients: does Pretreatment with Pertuzumab Matter?
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Enrichetta Valle | 1 | 14 | 22 | 12 | 2 | 27 | |
| Hannes Fohler | 3 | 24 | 29 | 5 | 3 | 36 | |
| Serhii Shevnia | 3 | 14 | 21 | 4 | 4 | 30 | |
| Nicolien van Ravesteyn | 6 | 27 | 2 | 4 | 36 | ||
| Mark Kuo | 14 | 28 | 11 | 3 | 37 | ||
| Alexandra Carmel | 24 | 9 | 5 | 4 | 32 | ||
| William Varnado | 3 | 7 | 17 | 2 | 21 | ||
| Ana Bosch Campos | 1 | 10 | 15 | 7 | 3 | 35 | |
| Hafiz Algurafi | 7 | 23 | 10 | 2 | 35 | ||
| Eveline Koiter | 8 | 12 | 5 | 4 | 31 | ||
| Kim van der Zande | 12 | 6 | 14 | 3 | 20 |
All Works
Loading papers...